Los puntos clave no están disponibles para este artículo en este momento.
SARM1, an NAD-utilizing enzyme, regulates axonal degeneration. We show that CZ-48, a cell-permeant mimetic of NMN, activated SARM1 in vitro and in cellulo to cyclize NAD and produce a Ca2+ messenger, cADPR, with similar efficiency as NMN. Knockout of NMN-adenylyltransferase elevated cellular NMN and activated SARM1 to produce cADPR, confirming NMN was its endogenous activator. Determinants for the activating effects and cell permeability of CZ-48 were identified. CZ-48 activated SARM1 via a conformational change of the auto-inhibitory domain and dimerization of its catalytic domain. SARM1 catalysis was similar to CD38, despite having no sequence similarity. Both catalyzed similar set of reactions, but SARM1 had much higher NAD-cyclizing activity, making it more efficient in elevating cADPR. CZ-48 acted selectively, activating SARM1 but inhibiting CD38. In SARM1-overexpressing cells, CZ-48 elevated cADPR, depleted NAD and ATP, and induced non-apoptotic death. CZ-48 is a specific modulator of SARM1 functions in cells.
Building similarity graph...
Analyzing shared references across papers
Loading...
Zhi Ying Zhao
Peking University
Xu Jie Xie
Peking University
Wan Hua Li
Chinese University of Hong Kong
SHILAP Revista de lepidopterología
iScience
Peking University
Building similarity graph...
Analyzing shared references across papers
Loading...
Zhao et al. (Wed,) studied this question.
synapsesocial.com/papers/69d95d778988aeabbe684fed — DOI: https://doi.org/10.1016/j.isci.2019.05.001
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: